These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11684603)

  • 1. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.
    Des Jarlais DC; Fisher DG; Newman JC; Trubatch BN; Yancovitz M; Paone D; Perlman D
    Am J Public Health; 2001 Nov; 91(11):1791-2. PubMed ID: 11684603
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence to hepatitis B virus vaccination at syringe exchange sites.
    Altice FL; Bruce RD; Walton MR; Buitrago MI
    J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.
    Lum PJ; Ochoa KC; Hahn JA; Page Shafer K; Evans JL; Moss AR;
    Am J Public Health; 2003 Jun; 93(6):919-23. PubMed ID: 12773355
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.
    Bowman S; Grau LE; Singer M; Scott G; Heimer R
    BMC Public Health; 2014 Aug; 14():820. PubMed ID: 25107530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccination in prisons.
    Awofeso N
    Bull World Health Organ; 2002; 80(7):569-74. PubMed ID: 12163921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination among research participants, Seattle, Washington.
    Hagan H; Thiede H; McGough JP; Alexander ER
    Am J Public Health; 2002 Nov; 92(11):1756. PubMed ID: 12406801
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination strategies for targeted and difficult-to-access groups.
    Trubatch BN; Fisher DG; Cagle HH; Fenaughty AM
    Am J Public Health; 2000 Mar; 90(3):447. PubMed ID: 10705870
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential of specialist drug services to deliver hepatitis B vaccination.
    Morrison DS; Gilchrist G; Ahmed S
    Commun Dis Public Health; 2002 Dec; 5(4):321-3. PubMed ID: 12564250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccine uptake among injecting drug users.
    Lawson J; Holtby I; Eynon C
    J Public Health (Oxf); 2004 Mar; 26(1):116-7. PubMed ID: 15044587
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.
    Bialek SR; Bower WA; Mottram K; Purchase D; Nakano T; Nainan O; Williams IT; Bell BP
    J Urban Health; 2005 Sep; 82(3):468-78. PubMed ID: 16049202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Working at the sharp end. Interview by Leona Armstrong.
    Kirk W
    Nurs Times; 2002 Dec 10-16; 98(50):44-5. PubMed ID: 12518553
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge of hepatitis among active drug injectors at a syringe exchange program.
    Carey J; Perlman DC; Friedmann P; Kaplan WM; Nugent A; Deutscher M; Masson CL; Des Jarlais DC
    J Subst Abuse Treat; 2005 Jul; 29(1):47-53. PubMed ID: 15979531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination for injection drug users--Pierce County, Washington, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 May; 50(19):388-90, 399. PubMed ID: 11465908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A
    Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denmark scales up hepatitis B screening and vaccination for risk groups.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.4. PubMed ID: 16794275
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic evaluation of delivering hepatitis B vaccine to injection drug users.
    Hu Y; Grau LE; Scott G; Seal KH; Marshall PA; Singer M; Heimer R
    Am J Prev Med; 2008 Jul; 35(1):25-32. PubMed ID: 18541174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.
    Hagan H; Jarlais DC; Friedman SR; Purchase D; Alter MJ
    Am J Public Health; 1995 Nov; 85(11):1531-7. PubMed ID: 7485666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An accelerated hepatitis B vaccination schedule for young drug users.
    Rogers N; Lubman DI
    Aust N Z J Public Health; 2005 Aug; 29(4):305-7. PubMed ID: 16222924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and vaccination against hepatitis].
    de la Briére A; Berenguerb M; Destombesa C
    Soins; 2013 Nov; (780):29-31. PubMed ID: 24409612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBV vaccination should be performed in service centres for drug users: an Italian experience.
    Quaglio G; Lugoboni F; Mezzelani P
    J Public Health (Oxf); 2004 Sep; 26(3):320. PubMed ID: 15454609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.